Attractnet

Intervention

1 paper1 finding

  • 1 lab in 1 country
  • Human trial1

Associations

1

Transthyretin amyloid cardiomyopathy

upin humans1

1 study
  1. Attractnet predicts transthyretin amyloid cardiomyopathy in humans (AUC 0.85).

    “It had good discrimination for ATTR-CM detection with an area under the receiver operator characteristic curve of 0.85 (5-fold cross-validation, 0.77-0.85) in the internal set”

    Human trialinternal test set

    Detecting Transthyretin Cardiac Amyloidosis With Artificial Intelligence: A Nonrandomized Clinical Trial

    JAMA cardiology10 Nov 2025

More on Transthyretin amyloid cardiomyopathy

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months